Jlb & Associates Inc Eli Lilly & CO Transaction History

Jlb & Associates Inc

$725 Million
Q3 2024

A detailed history of Jlb & Associates Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Jlb & Associates Inc holds 14,153 shares of LLY stock, worth $10.9 Million. This represents 1.73% of its overall portfolio holdings.

Number of Shares

14,153

Previous 15,389 8.03%

Holding current value

$10.9 Million

Previous $13.9 Million 10.01%

% of portfolio

1.73%

Previous 2.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 02, 2024	SELL	$772.14 - $960.02 $954,365 - $1.19 Million	-1,236 Reduced 8.03%	14,153 $12.5 Million
Q2 2024 Jul 18, 2024	SELL	$724.87 - $909.04 $703,123 - $881,768	-970 Reduced 5.93%	15,389 $13.9 Million
Q1 2024 Apr 30, 2024	SELL	$592.2 - $792.28 $599,306 - $801,787	-1,012 Reduced 5.83%	16,359 $12.7 Million
Q4 2023 Jan 22, 2024	SELL	$525.19 - $619.13 $362,381 - $427,199	-690 Reduced 3.82%	17,371 $10.1 Million
Q3 2023 Nov 01, 2023	SELL	$434.7 - $599.3 $2.99 Million - $4.12 Million	-6,881 Reduced 27.59%	18,061 $9.7 Million
Q2 2023 Jul 20, 2023	SELL	$350.74 - $468.98 $548,908 - $733,953	-1,565 Reduced 5.9%	24,942 $11.7 Million
Q1 2023 Apr 25, 2023	BUY	$310.63 - $364.82 $719,419 - $844,923	2,316 Added 9.57%	26,507 $9.1 Million
Q4 2022 Jan 26, 2023	SELL	$321.55 - $374.67 $952,431 - $1.11 Million	-2,962 Reduced 10.91%	24,191 $8.85 Million
Q3 2022 Oct 19, 2022	SELL	$296.48 - $337.87 $131,637 - $150,014	-444 Reduced 1.61%	27,153 $8.78 Million
Q2 2022 Jul 19, 2022	SELL	$278.73 - $327.27 $416,143 - $488,614	-1,493 Reduced 5.13%	27,597 $8.95 Million
Q1 2022 Apr 08, 2022	SELL	$234.69 - $291.66 $130,018 - $161,579	-554 Reduced 1.87%	29,090 $8.33 Million
Q4 2021 Jan 26, 2022	SELL	$224.85 - $279.04 $277,689 - $344,614	-1,235 Reduced 4.0%	29,644 $8.19 Million
Q3 2021 Nov 10, 2021	SELL	$221.6 - $272.71 $407,744 - $501,786	-1,840 Reduced 5.62%	30,879 $7.13 Million
Q1 2021 May 13, 2021	SELL	$164.32 - $212.72 $47,652 - $61,688	-290 Reduced 0.88%	32,719 $6.11 Million
Q4 2020 Jan 28, 2021	BUY	$130.46 - $172.63 $19,438 - $25,721	149 Added 0.45%	33,009 $5.57 Million
Q3 2020 Oct 16, 2020	SELL	$146.22 - $169.13 $110,396 - $127,693	-755 Reduced 2.25%	32,860 $4.86 Million
Q2 2020 Jul 13, 2020	BUY	$136.42 - $164.18 $18,689 - $22,492	137 Added 0.41%	33,615 $5.52 Million
Q1 2020 May 19, 2020	BUY	$119.05 - $147.35 $139,526 - $172,694	1,172 Added 3.63%	33,478 $4.64 Million
Q4 2019 Feb 10, 2020	BUY	$106.92 - $132.43 $24,912 - $30,856	233 Added 0.73%	32,306 $4.25 Million
Q3 2019 Oct 29, 2019	BUY	$106.79 - $116.16 $102,411 - $111,397	959 Added 3.08%	32,073 $3.59 Million
Q2 2019 Aug 05, 2019	BUY	$110.79 - $129.32 $314,643 - $367,268	2,840 Added 10.04%	31,114 $3.45 Million
Q1 2019 Apr 30, 2019	BUY	$111.31 - $131.02 $6,122 - $7,206	55 Added 0.19%	28,274 $3.67 Million
Q4 2017 Jan 24, 2018	BUY	$81.94 - $87.89 $21,140 - $22,675	258 Added 0.92%	28,219 $2.38 Million
Q3 2017 Oct 12, 2017	BUY	$77.07 - $85.54 $2.15 Million - $2.39 Million	27,961	27,961 $2.39 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $730B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jlb & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jlb & Associates Inc with notifications on news.

Account

Jlb & Associates Inc Eli Lilly & CO Transaction History